• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻求顺势疗法和非手术性白内障治疗方法。

The quest for homeopathic and nonsurgical cataract treatment.

机构信息

Shiley Eye Institute, University of California San Diego, La Jolla, California, USA.

出版信息

Curr Opin Ophthalmol. 2020 Jan;31(1):61-66. doi: 10.1097/ICU.0000000000000631.

DOI:10.1097/ICU.0000000000000631
PMID:31770163
Abstract

PURPOSE OF REVIEW

Age-related cataract occurs when crystallin proteins in the lens partially unfold and subsequently aggregate. Physicians and traditional healers alike have been exploring pharmacologic cataract treatment for hundreds of years. Currently, surgery is the only effective treatment. However, there are an abundance of homeopathic and alternative remedies that have been suggested as treatment for cataract. This article reviews the current understanding of cataract development and discusses several homeopathic remedies purported to treat age-related cataract. Additionally, we will present an overview of evidence regarding the development of pharmacologic cataract reversal therapies.

RECENT FINDINGS

Some homeopathic therapies have been shown to prevent cataract development in experimental models. More studies are required to elucidate the potential medicinal and toxic properties of the various alternative therapies. However, in recent years, scientists have begun to investigate substances that address cataract by reversing lens protein aggregation. One such compound, lanosterol, was reported to reverse cataract opacity in vitro and in animal models. Subsequently, 25-hydroxycholesterol and rosmarinic acid were identified as having similar properties.

SUMMARY

Although challenges and uncertainties remain, further research has the potential to lead to the development of a nonsurgical therapeutic option for age-related cataract.

摘要

目的综述

晶状体蛋白部分展开并随后聚集时,就会发生年龄相关性白内障。数百年来,医生和传统治疗师一直在探索治疗白内障的药物。目前,手术是唯一有效的治疗方法。但是,有大量顺势疗法和替代疗法被认为可用于治疗白内障。本文综述了白内障发展的现有认识,并讨论了几种据称可治疗年龄相关性白内障的顺势疗法。此外,我们还将概述有关药物性白内障逆转治疗发展的证据。

最近的发现

一些顺势疗法已被证明可预防实验模型中的白内障发展。需要进行更多的研究来阐明各种替代疗法的潜在药用和毒性特性。但是,近年来,科学家开始研究通过逆转晶状体蛋白聚集来治疗白内障的物质。一种这样的化合物羊毛甾醇被报道可在体外和动物模型中逆转白内障混浊。随后,发现 25-羟基胆固醇和迷迭香酸具有类似的特性。

总结

尽管仍然存在挑战和不确定性,但进一步的研究有可能为年龄相关性白内障开发出一种非手术治疗选择。

相似文献

1
The quest for homeopathic and nonsurgical cataract treatment.寻求顺势疗法和非手术性白内障治疗方法。
Curr Opin Ophthalmol. 2020 Jan;31(1):61-66. doi: 10.1097/ICU.0000000000000631.
2
Rosmarinic Acid Restores Complete Transparency of Sonicated Human Cataract Ex Vivo and Delays Cataract Formation In Vivo.迷迭香酸使超声处理的人白内障恢复完全透明并延缓体内白内障形成。
Sci Rep. 2018 Jun 19;8(1):9341. doi: 10.1038/s41598-018-27516-9.
3
Lanosterol and 25-hydroxycholesterol dissociate crystallin aggregates isolated from cataractous human lens via different mechanisms.羊毛固醇和 25-羟胆固醇通过不同的机制解离白内障人晶状体分离的晶状体聚集物。
Biochem Biophys Res Commun. 2018 Dec 2;506(4):868-873. doi: 10.1016/j.bbrc.2018.10.175. Epub 2018 Nov 2.
4
Advances in pharmacotherapy of cataracts.白内障药物治疗的进展。
Ann Transl Med. 2020 Nov;8(22):1552. doi: 10.21037/atm-20-1960.
5
Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts.甾醇氧化物(如羊毛甾醇)无法使白内障晶状体恢复透明。
Sci Rep. 2019 Jun 11;9(1):8459. doi: 10.1038/s41598-019-44676-4.
6
Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action.迷迭香酸的保肝作用:作用机制的研究进展。
Biomed Pharmacother. 2019 Apr;112:108600. doi: 10.1016/j.biopha.2019.108600. Epub 2019 Feb 16.
7
Protective Effects of Rosmarinic Acid against Selenite-Induced Cataract and Oxidative Damage in Rats.迷迭香酸对亚硒酸钠诱导的大鼠白内障及氧化损伤的保护作用。
Int J Med Sci. 2019 May 10;16(5):729-740. doi: 10.7150/ijms.32222. eCollection 2019.
8
Pharmacological chaperone for α-crystallin partially restores transparency in cataract models.α-晶状体蛋白的药理学伴侣分子可部分恢复白内障模型的透明度。
Science. 2015 Nov 6;350(6261):674-7. doi: 10.1126/science.aac9145.
9
Pharmacological approaches to restoring lens transparency: Real world applications.恢复晶状体透明度的药理学方法:实际应用
Ophthalmic Genet. 2017 May-Jun;38(3):201-205. doi: 10.1080/13816810.2016.1214971. Epub 2016 Sep 20.
10
Peptide-based treatment strategies for cataract.基于肽的白内障治疗策略。
J Glaucoma. 2014 Oct-Nov;23(8 Suppl 1):S73-6. doi: 10.1097/IJG.0000000000000111.

引用本文的文献

1
Influence of Different Cationic Polymer-Based Micelles on the Corneal Behavior and Anti-Cataract Effect of Diosmetin.不同阳离子聚合物基胶束对香叶木素角膜行为及抗白内障作用的影响
Pharmaceutics. 2025 Feb 25;17(3):302. doi: 10.3390/pharmaceutics17030302.
2
Measuring the viability of crystalline lens epithelial cells by triple Hoechst-Ethidium-Calcein-AM staining.通过三重Hoechst-溴化乙锭-钙黄绿素-AM染色法检测晶状体上皮细胞的活力
Mol Vis. 2024 Dec 31;30:478-487. eCollection 2024.
3
Oxidative Stress in Cataract Formation: Is There a Treatment Approach on the Horizon?
白内障形成中的氧化应激:是否即将出现一种治疗方法?
Antioxidants (Basel). 2024 Oct 16;13(10):1249. doi: 10.3390/antiox13101249.
4
Therapeutic Applications of Oxysterols and Derivatives in Age-Related Diseases, Infectious and Inflammatory Diseases, and Cancers.氧化固醇及其衍生物在与年龄相关的疾病、感染和炎症性疾病以及癌症中的治疗应用。
Adv Exp Med Biol. 2024;1440:379-400. doi: 10.1007/978-3-031-43883-7_19.
5
Impact of Oxysterols in Age-Related Disorders and Strategies to Alleviate Adverse Effects.氧化甾醇在与年龄相关疾病中的影响及减轻不良反应的策略。
Adv Exp Med Biol. 2024;1440:163-191. doi: 10.1007/978-3-031-43883-7_9.
6
Investigation of the scattering and attenuation properties of cataracts formed in mouse eyes with 1060-nm and 1310-nm swept-source optical coherence tomography.利用1060纳米和1310纳米扫频源光学相干断层扫描技术对小鼠眼睛中形成的白内障的散射和衰减特性进行研究。
Biomed Opt Express. 2021 Sep 20;12(10):6391-6406. doi: 10.1364/BOE.433927. eCollection 2021 Oct 1.
7
Advances in pharmacotherapy of cataracts.白内障药物治疗的进展。
Ann Transl Med. 2020 Nov;8(22):1552. doi: 10.21037/atm-20-1960.
8
Recent developments in cataract surgery.白内障手术的最新进展。
Ann Transl Med. 2020 Nov;8(22):1540. doi: 10.21037/atm-2020-rcs-16.